133 related articles for article (PubMed ID: 7961262)
1. Pulmonary arterial smooth muscle contractility in hypoxia-induced pulmonary hypertension.
Griffith SL; Rhoades RA; Packer CS
J Appl Physiol (1985); 1994 Jul; 77(1):406-14. PubMed ID: 7961262
[TBL] [Abstract][Full Text] [Related]
2. Porcine pulmonary artery and bronchial responses to endothelin-1 and norepinephrine on recovery from hypoxic pulmonary hypertension.
Schindler MB; Hislop AA; Haworth SG
Pediatr Res; 2006 Jul; 60(1):71-6. PubMed ID: 16690956
[TBL] [Abstract][Full Text] [Related]
3. Macrophage migration inhibitory factor contributes to hypoxic pulmonary vasoconstriction in rats.
Zhang B; Luo Y; Liu ML; Wang J; Xu DQ; Dong MQ; Liu Y; Xu M; Dong HY; Zhao PT; Gao YQ; Li ZC
Microvasc Res; 2012 Mar; 83(2):205-12. PubMed ID: 22005047
[TBL] [Abstract][Full Text] [Related]
4. [Mechanisms of remodeling of pulmonary blood vessels in chronic hypoxia].
Herget J; Bíbová J; Novotná J
Cesk Fysiol; 1999 Nov; 48(4):179-84. PubMed ID: 10748761
[TBL] [Abstract][Full Text] [Related]
5. [Effects of early digoxin treatment on hypoxia-induced pulmonary artery hypertension].
Yan G; Hu S; Wang Q; Wang D; Wang J; Qiao Y; Tang C; Ma G; Gu Y
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):139-43. PubMed ID: 24721356
[TBL] [Abstract][Full Text] [Related]
6. Reversal of chronic hypoxia-induced alterations in pulmonary artery smooth muscle electromechanical coupling upon air breathing.
Bonnet S; Dubuis E; Vandier C; Martin S; Marthan R; Savineau JP
Cardiovasc Res; 2002 Mar; 53(4):1019-28. PubMed ID: 11922912
[TBL] [Abstract][Full Text] [Related]
7. In vivo gene transfer of the O2-sensitive potassium channel Kv1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronically hypoxic rats.
Pozeg ZI; Michelakis ED; McMurtry MS; Thébaud B; Wu XC; Dyck JR; Hashimoto K; Wang S; Moudgil R; Harry G; Sultanian R; Koshal A; Archer SL
Circulation; 2003 Apr; 107(15):2037-44. PubMed ID: 12695303
[TBL] [Abstract][Full Text] [Related]
8. Chronic Normobaric Hypoxia Induces Pulmonary Hypertension in Rats: Role of NF-κB.
Fan J; Fan X; Li Y; Ding L; Zheng Q; Guo J; Xia D; Xue F; Wang Y; Liu S; Gong Y
High Alt Med Biol; 2016 Mar; 17(1):43-9. PubMed ID: 26788753
[TBL] [Abstract][Full Text] [Related]
9. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
[TBL] [Abstract][Full Text] [Related]
10. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
[TBL] [Abstract][Full Text] [Related]
11. Myosin isoform shifts and decreased reactivity in hypoxia-induced hypertensive pulmonary arterial muscle.
Packer CS; Roepke JE; Oberlies NH; Rhoades RA
Am J Physiol; 1998 May; 274(5):L775-85. PubMed ID: 9612293
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary artery smooth muscle activation attenuates arterial dysfunction during acute pulmonary hypertension.
Santana DB; Barra JG; Grignola JC; Ginés FF; Armentano RL
J Appl Physiol (1985); 2005 Feb; 98(2):605-13. PubMed ID: 15489257
[TBL] [Abstract][Full Text] [Related]
13. Hypoxic exposure time dependently modulates endothelin-induced contraction of pulmonary artery smooth muscle.
Bialecki RA; Fisher CS; Murdoch WW; Barthlow HG; Stow RB; Mallamaci M; Rumsey W
Am J Physiol; 1998 Apr; 274(4):L552-9. PubMed ID: 9575873
[TBL] [Abstract][Full Text] [Related]
14. Involvement of CapG in proliferation and apoptosis of pulmonary arterial smooth muscle cells and in hypoxia-induced pulmonary hypertension rat model.
Xu X; Hu H; Wang X; Ye W; Su H; Hu Y; Dong L; Zhang R; Ying K
Exp Lung Res; 2016 Apr; 42(3):142-53. PubMed ID: 27093378
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension.
Sebkhi A; Strange JW; Phillips SC; Wharton J; Wilkins MR
Circulation; 2003 Jul; 107(25):3230-5. PubMed ID: 12796132
[TBL] [Abstract][Full Text] [Related]
16. [Effect of polycythemia on hypoxia induced pulmonary hypertension and pulmonary vascular remodeling in rats].
Zhou YR; Zhou TF; Ouzhuluobu ; Qiao LN; Wang XQ; Xu HB; Liu HM; Hua YM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):619-22. PubMed ID: 19764557
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 inhibition and hypoxia-induced pulmonary hypertension: effects on pulmonary vascular remodeling and contractility.
Fredenburgh LE; Ma J; Perrella MA
Trends Cardiovasc Med; 2009 Feb; 19(2):31-7. PubMed ID: 19577709
[TBL] [Abstract][Full Text] [Related]
18. Activated TAFI Promotes the Development of Chronic Thromboembolic Pulmonary Hypertension: A Possible Novel Therapeutic Target.
Satoh T; Satoh K; Yaoita N; Kikuchi N; Omura J; Kurosawa R; Numano K; Al-Mamun E; Siddique MA; Sunamura S; Nogi M; Suzuki K; Miyata S; Morser J; Shimokawa H
Circ Res; 2017 Apr; 120(8):1246-1262. PubMed ID: 28289017
[TBL] [Abstract][Full Text] [Related]
19. Primary pulmonary hypertension.
Hogg JC
Chest; 1988 Mar; 93(3 Suppl):172S-175S. PubMed ID: 3277817
[No Abstract] [Full Text] [Related]
20. Quercetin reverses experimental pulmonary arterial hypertension by modulating the TrkA pathway.
He Y; Cao X; Liu X; Li X; Xu Y; Liu J; Shi J
Exp Cell Res; 2015 Nov; 339(1):122-34. PubMed ID: 26476374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
